{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:56:26Z","timestamp":1781204186280,"version":"3.54.1"},"reference-count":45,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,5,29]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Both dermatological and neurological manifestations characterise neurocutaneous syndromes (NCSs). Although individually rare, collectively they impose a substantial clinical, humanitarian and economic burden, often contributing to barriers in healthcare access. This scoping review aims to map global evidence on healthcare access and service utilisation in NCSs and identify barriers, facilitators and gaps in care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This scoping review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines. Bibliographic databases and hand searches will be used to identify relevant studies. Published and grey literature addressing healthcare access will be included while non-English studies will be excluded. Two independent reviewers will perform study selection and data extraction. Quality assessment will be conducted for full-text studies using the Joanna Briggs Institute tools. Findings will be mapped to evidence on healthcare access, service utilisation, treatment patterns, barriers and facilitators and will be presented using tables and geographic mapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This scoping review will use publicly available data and therefore does not require ethical approval. The findings will be published in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116737","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:00:13Z","timestamp":1781200813000},"page":"e116737","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring global access to healthcare and utilisation for neurocutaneous syndromes: a scoping review protocol"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-8228","authenticated-orcid":false,"given":"Bezie","family":"Kebede","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Bahir Dar University, Bahir Dar, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebaw","family":"Molla","sequence":"additional","affiliation":[{"name":"Department of Public Health, Injibara University, Injibara, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4126-0939","authenticated-orcid":false,"given":"Bezuayehu","family":"Alemayehu","sequence":"additional","affiliation":[{"name":"Department of Public Health, Mizan-Tepi University, Mizan Teferi, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"2026061111000619000_16.6.e116737.1","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1097\/JS9.0000000000001816","article-title":"Neurocutaneous syndromes","volume":"110","author":"Qin","year":"2024","journal-title":"Int J Surg"},{"key":"2026061111000619000_16.6.e116737.2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1659708"},{"key":"2026061111000619000_16.6.e116737.3","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-019-1258-3","article-title":"A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)","volume":"15","author":"Z\u00f6llner","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2026061111000619000_16.6.e116737.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-025-03975-y","article-title":"Burden of illness in tuberous sclerosis complex-associated epilepsy: a systematic literature review of epidemiology, health-related quality of life, costs and resource use","volume":"20","author":"Furber","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"2026061111000619000_16.6.e116737.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026061111000619000_16.6.e116737.6","doi-asserted-by":"crossref","unstructured":"Sotiropoulou L , Loupas MA , Adamopoulou M , et al . Economic burden and health-related quality of life in patients with neurofibromatosis type 1 in Greece. Open Health 2023;4. doi:10.1515\/ohe-2023-0017","DOI":"10.1515\/ohe-2023-0017"},{"key":"2026061111000619000_16.6.e116737.7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081831","article-title":"Non-Oncological Neuroradiological Manifestations in NF1 and Their Clinical Implications","volume":"13","author":"Russo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026061111000619000_16.6.e116737.8","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.3390\/app10144687","article-title":"Oral Clinical Manifestations of Neurofibromatosis Type 1 in Children and Adolescents","volume":"10","author":"Santoro","year":"2020","journal-title":"Appl Sci (Basel)"},{"key":"2026061111000619000_16.6.e116737.9","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2272(200012)19:4<429::AID-GEPI13>3.0.CO;2-N"},{"key":"2026061111000619000_16.6.e116737.10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nrleng.2019.05.008","article-title":"Neurological manifestations of neurofibromatosis type 1: our experience","volume":"37","author":"S\u00e1nchez Marco","year":"2022","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"2026061111000619000_16.6.e116737.11","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/JMDH.S362791","article-title":"Neurofibromatosis Type 1: Optimizing Management with a Multidisciplinary Approach","volume":"17","author":"Lalvani","year":"2024","journal-title":"J Multidiscip Healthc"},{"key":"2026061111000619000_16.6.e116737.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-012-0269-4"},{"key":"2026061111000619000_16.6.e116737.13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13061648","article-title":"Neurocutaneous Diseases: Diagnosis, Management, and Treatment","volume":"13","author":"Kioutchoukova","year":"2024","journal-title":"J Clin Med"},{"key":"2026061111000619000_16.6.e116737.14","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-021-00281-0","article-title":"MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions","volume":"9","author":"Harder","year":"2021","journal-title":"Biomark Res"},{"key":"2026061111000619000_16.6.e116737.15","doi-asserted-by":"crossref","first-page":"1642299","DOI":"10.3389\/fneur.2025.1642299","article-title":"Progress in genetic mechanisms and precise treatment of neurocutaneous syndrome-related epilepsy","volume":"16","author":"Li","year":"2025","journal-title":"Front Neurol"},{"key":"2026061111000619000_16.6.e116737.16","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00381-022-05513-8","article-title":"Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA","volume":"38","author":"Yang","year":"2022","journal-title":"Childs Nerv Syst"},{"key":"2026061111000619000_16.6.e116737.17","doi-asserted-by":"crossref","DOI":"10.3171\/2022.2.FOCUS21776","article-title":"Multidisciplinary neurocutaneous syndrome clinics: a systematic review and institutional experience","volume":"52","author":"Grossen","year":"2022","journal-title":"Neurosurg Focus"},{"key":"2026061111000619000_16.6.e116737.18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.34172\/hpp.2023.05","article-title":"Access to medicines through global health diplomacy","volume":"13","author":"Chattu","year":"2023","journal-title":"Health Promot Perspect"},{"key":"2026061111000619000_16.6.e116737.19","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02667-9","article-title":"Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review","volume":"18","author":"Gittus","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026061111000619000_16.6.e116737.20","unstructured":"Andreu P , Karam J , Child C , et al . The Burden of Rare Diseases: An Economic Evaluation. 2022."},{"key":"2026061111000619000_16.6.e116737.21","doi-asserted-by":"publisher","DOI":"10.1258\/135581902760082517"},{"key":"2026061111000619000_16.6.e116737.22","doi-asserted-by":"publisher","DOI":"10.1186\/1475-9276-12-18"},{"key":"2026061111000619000_16.6.e116737.23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0045-1806922"},{"key":"2026061111000619000_16.6.e116737.24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2018.08.006","article-title":"Genetic Evaluation of Common Neurocutaneous Syndromes","volume":"89","author":"G\u00fcrsoy","year":"2018","journal-title":"Pediatr Neurol"},{"key":"2026061111000619000_16.6.e116737.25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.20344\/amp.19063","article-title":"Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases: Five-year Experience of a Pediatric Tertiary Hospital in Portugal","volume":"37","author":"Rebelo","year":"2024","journal-title":"Acta Med Port"},{"key":"2026061111000619000_16.6.e116737.26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12687-024-00721-y","article-title":"Knowledge, attitudes, and practices of primary healthcare practitioners in low- and middle-income countries: a scoping review on genetics","volume":"15","author":"Walters","year":"2024","journal-title":"J Community Genet"},{"key":"2026061111000619000_16.6.e116737.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-025-03838-6","article-title":"Criteria to evaluate unmet health-related needs of persons living with rare diseases and their caregivers: rapid literature review and stakeholder consultations","volume":"20","author":"Claessens","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"2026061111000619000_16.6.e116737.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104609","article-title":"Ensuring access to multidisciplinary care in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 4)","volume":"84","author":"Paluch-Shimon","year":"2025","journal-title":"Breast"},{"key":"2026061111000619000_16.6.e116737.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-087451","article-title":"Barriers and facilitators for strengthening primary health systems for person-centred multimorbid care in low-income and middle-income countries: a scoping review","volume":"14","author":"Zezai","year":"2024","journal-title":"BMJ Open"},{"key":"2026061111000619000_16.6.e116737.30","doi-asserted-by":"publisher","DOI":"10.4300\/JGME-D-22-00620.1"},{"key":"2026061111000619000_16.6.e116737.31","doi-asserted-by":"publisher","DOI":"10.1111\/wvn.12144"},{"key":"2026061111000619000_16.6.e116737.32","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2026061111000619000_16.6.e116737.33","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000050"},{"key":"2026061111000619000_16.6.e116737.34","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-20-00167"},{"key":"2026061111000619000_16.6.e116737.35","unstructured":"McInerney P , Baldini Soares C , Khalil H , et al . Methodology for JBI scoping reviews. 2015."},{"key":"2026061111000619000_16.6.e116737.36","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-024-02476-6","article-title":"The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis","volume":"13","author":"Faramarzi","year":"2024","journal-title":"Syst Rev"},{"key":"2026061111000619000_16.6.e116737.37","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/ajmg.a.62773","article-title":"A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1","volume":"188","author":"Crow","year":"2022","journal-title":"Am J Med Genet A"},{"key":"2026061111000619000_16.6.e116737.38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaac.2024.09.011","article-title":"Systematic Review and Meta-Analysis: Attention-Deficit\/Hyperactivity Disorder Symptoms in Children With Neurofibromatosis Type 1","volume":"64","author":"Hou","year":"2025","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2026061111000619000_16.6.e116737.39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061119","article-title":"A Systematic Review of Diagnostic Modalities and Strategies for the Assessment of Complications in Adult Patients with Neurofibromatosis Type 1","volume":"16","author":"Rana","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026061111000619000_16.6.e116737.40","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1296239","article-title":"Service-level barriers to and facilitators of accessibility to treatment for problematic alcohol use: a scoping review","volume":"11","author":"Wolfe","year":"2023","journal-title":"Front Public Health"},{"key":"2026061111000619000_16.6.e116737.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298973","article-title":"Access of older people to primary health care in low and middle-income countries: A systematic scoping review","volume":"19","author":"Dableh","year":"2024","journal-title":"PLoS One"},{"key":"2026061111000619000_16.6.e116737.42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ajs4.70026","article-title":"A Scoping Review of Access and Engagement With Mental Health Services by Young People From Culturally and Linguistically Diverse Communities in Australia","volume":"60","author":"Poon","year":"2025","journal-title":"Aust J Social Issues"},{"key":"2026061111000619000_16.6.e116737.43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40258-024-00939-4","article-title":"Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases","volume":"23","author":"Vargas","year":"2025","journal-title":"Appl Health Econ Health Policy"},{"key":"2026061111000619000_16.6.e116737.44","unstructured":"Joanna Briggs Institute . JBI critical appraisal tools: Adelaide, 2020. Available: https:\/\/jbi.global\/critical-appraisal-tools"},{"key":"2026061111000619000_16.6.e116737.45","unstructured":"Sowden A , Petticrew M , Arai L , et al . Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC methods programme. Lancaster University, 2006."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:00:20Z","timestamp":1781200820000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,11]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjopen-2026-116737"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116737","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}